Roche Executive and Leadership Team

Isabel Ladd, the Chief Executive Officer at Roche, directs the overarching corporate strategy and operational execution. Ladd guides the company's dual focus on pioneering pharmaceuticals and advanced diagnostics, ensuring alignment with the mission to improve people's lives through innovative healthcare. This leadership role involves setting the strategic direction for global operations, fostering a culture of scientific excellence, and driving the company's commitment to personalized healthcare. Ladd oversees the integration of research and development efforts across major therapeutic areas, including oncology and immunology, and ensures the diagnostics division effectively supports disease detection and management. The Chief Executive Officer's responsibilities extend to maintaining Roche's leading positions in both market segments and championing collaborations that accelerate the development of targeted therapies and companion diagnostics. By steering the company's global presence, Isabel Ladd ensures Roche remains at the forefront of transforming patient care and addressing critical health challenges worldwide.

Douglas McIntosh, the Chief Financial Officer, Genentech Patient Foundation at Roche, manages the financial operations and strategic fiscal planning for the foundation. McIntosh oversees the allocation of resources to support patient access programs and the foundation's mission, ensuring financial sustainability and compliance. This critical role involves developing budgets, managing investments, and providing financial insights to guide the foundation's initiatives in enhancing patient care. The Chief Financial Officer, Genentech Patient Foundation ensures that financial strategies align with the broader goals of improving lives through innovative healthcare solutions, particularly for patients benefiting from Genentech's therapies. McIntosh's responsibilities include financial reporting, risk management, and optimizing financial performance to maximize the impact of the foundation's work. By maintaining rigorous financial oversight, Douglas McIntosh enables the Genentech Patient Foundation to effectively support patients and contribute to Roche's commitment to accessible, advanced healthcare.

Maria del Pilar Camacho, the Director, Finance & Administrative & Chief Financial Officer at Roche, directs financial operations and administrative functions. Camacho oversees the fiscal health of the organization, managing budgets, financial planning, and resource allocation to support Roche's strategic objectives in pharmaceuticals and diagnostics. This role is crucial for ensuring the financial stability and growth required to advance scientific innovation and improve patient outcomes. The Director, Finance & Administrative & Chief Financial Officer ensures compliance with financial regulations and optimizes financial performance across all business units. Camacho's responsibilities include providing strategic financial guidance, managing investments, and overseeing administrative processes that support efficient operations. By maintaining robust financial management and administrative oversight, Maria del Pilar Camacho contributes significantly to Roche's capacity to develop and deliver life-changing healthcare solutions globally.

Agustín Amato, the Chief Financial Officer & Director, Finance Business Operations at Roche, manages the company's financial strategy and oversees critical finance business operations. Amato directs financial planning, analysis, and reporting, ensuring fiscal discipline and supporting strategic decision-making across Roche's pharmaceutical and diagnostics divisions. This leadership role is essential for driving sustainable growth and funding the company's extensive research and development initiatives. The Chief Financial Officer & Director, Finance Business Operations ensures that financial resources are optimally allocated to support innovation and market expansion, particularly in areas like oncology and personalized healthcare. Amato's responsibilities include enhancing operational efficiency within finance departments and providing strategic financial insights to executive leadership. Through rigorous financial oversight and operational management, Agustín Amato reinforces Roche's commitment to delivering impactful healthcare solutions and maintaining its position as a global leader in the industry.

Rupesh Chopra, the Head Chief Operating Officer, Cluster at Roche, directs operational strategies and execution across designated regional clusters. Chopra oversees the efficient functioning of business operations, ensuring alignment with Roche's global objectives in pharmaceuticals and diagnostics. This leadership position involves optimizing supply chains, managing site operations, and driving efficiency improvements to support the company's mission of advancing science for better health outcomes. The Head Chief Operating Officer, Cluster is responsible for implementing operational best practices, fostering a culture of continuous improvement, and ensuring the reliable delivery of innovative healthcare solutions. Chopra's purview includes managing resources effectively, mitigating operational risks, and enhancing productivity across the cluster. By focusing on operational excellence, Rupesh Chopra plays a key part in reinforcing Roche's global presence and its commitment to transforming patient care through robust and efficient operations.

Imene Ben Abdallah, the Chief of Staff at Roche, provides critical operational support and strategic counsel to the executive leadership team. Ben Abdallah facilitates the efficient functioning of executive operations, ensuring seamless communication and coordination across departments. This role involves managing key strategic initiatives, optimizing internal processes, and supporting the Chief Executive Officer in driving the company's mission forward. The Chief of Staff plays a vital part in translating high-level corporate objectives into actionable plans, particularly concerning Roche's dual focus on pharmaceuticals and diagnostics. Ben Abdallah coordinates cross-functional projects, enhances organizational effectiveness, and ensures that strategic priorities are effectively implemented across the global enterprise. By streamlining executive decision-making and fostering collaboration, Imene Ben Abdallah contributes significantly to Roche's ability to deliver innovative healthcare solutions and maintain its leadership in advancing science for improved patient outcomes.

Loretta De Souza, the Chief Marketing Officer & Global Quality Site Manager at Roche, spearheads global marketing strategies while ensuring stringent quality standards across operational sites. De Souza directs the commercialization efforts for Roche's innovative pharmaceutical and diagnostic products, focusing on communicating their value in advancing science and improving patient lives. This dual role requires a deep understanding of market dynamics and a commitment to operational excellence. The Chief Marketing Officer & Global Quality Site Manager oversees the development and execution of marketing campaigns that highlight Roche's leadership in areas like oncology and personalized healthcare. Simultaneously, De Souza manages quality assurance protocols, ensuring that manufacturing and operational processes meet the highest global benchmarks. By integrating marketing vision with quality management, Loretta De Souza drives both market penetration and the consistent delivery of reliable healthcare solutions, reinforcing Roche's reputation for innovation and dependability.

Mary Shan, the Chief Marketing Officer, Quality & Site Manager at Roche, leads marketing initiatives while overseeing quality management and site operations. Shan directs the strategic promotion of Roche's pharmaceutical and diagnostic offerings, emphasizing their role in personalized healthcare and disease management. This multifaceted role ensures that marketing efforts accurately reflect the company's commitment to scientific innovation and patient well-being. The Chief Marketing Officer, Quality & Site Manager is responsible for developing compelling market strategies and ensuring that all site operations adhere to the highest quality and safety standards. Shan's focus includes enhancing brand visibility, driving market adoption of new therapies and diagnostics, and maintaining operational integrity. By bridging marketing leadership with rigorous quality oversight, Mary Shan contributes to Roche's reputation for excellence and its ability to deliver impactful healthcare solutions globally.

John Pascual, the Global Chief Marketing Officer & Site Manager at Roche, drives global marketing strategies and manages site operations to ensure product success and quality. Pascual oversees the commercialization of Roche's diverse portfolio, focusing on communicating the value of its pharmaceutical and diagnostic innovations to healthcare professionals and patients worldwide. This leadership position requires a strategic vision for market penetration and a meticulous approach to operational management. The Global Chief Marketing Officer & Site Manager develops and implements integrated marketing plans that align with Roche's mission to improve lives through science. Simultaneously, Pascual ensures that site operations meet stringent quality benchmarks, supporting the reliable production and distribution of critical healthcare solutions. By unifying global marketing efforts with site-level quality control, John Pascual enhances Roche's market impact and operational reliability.

Yilmaz Akan, the Enterprise Agility Coach Transformation Lead & Chief Technology Officer, Digital Health Lead at Roche, drives technological innovation and agile transformation, particularly in digital health. Akan leads the strategic implementation of advanced technologies and agile methodologies to enhance Roche's digital health offerings and operational efficiency. This role is pivotal in shaping the future of healthcare through digital solutions, focusing on improving patient engagement and treatment outcomes. The Enterprise Agility Coach Transformation Lead & Chief Technology Officer, Digital Health Lead oversees the development and deployment of digital platforms, ensuring they align with Roche's mission of advancing science for better health. Akan's expertise in agility and technology fosters a culture of rapid innovation and adaptation within the organization. By championing digital transformation, Yilmaz Akan positions Roche at the forefront of leveraging technology to create more personalized and effective healthcare experiences.